Skip to content
healthcare.dev
Get a free key

Deferasirox

NDC 69097-570, Deferasirox, granule, from Cipla USA Inc..

Product NDC
69097-570
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215026
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-570 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX360 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
69097-570-536909705705330 PACKET in 1 CARTON (69097-570-53) / 1 GRANULE in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31c5a91f-e901-418b-a519-779a0c245477

Use it

Look up 69097-570 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-570 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-570. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.